Clinical Trial Update: Hematopoietic Cell Transplantation With Post-transplantation Cyclophosphamide in MDS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hematopoietic cell transplantation with post-transplant cyclophosphamide for myelodysplastic syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• post-transplantation cyclophosphamide (cyclophosphamide)

Snippet

Sponsor: Asan Medical Center | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED